Current Treatment Modalities for Wide Necked Intracranial Aneurysms

Status Active, not recruiting

Clinical Trial Summary

- Give an effective treatment for intracranial wide necked aneurysm and can detect the best method could be used.

- Improve the outcome of these patients and decease rate of recurrence and complications.

Clinical Trial Description

The prevalence of intracranial aneurysms in the adult population is estimated to be around 2 %. Most remain asymptomatic, but there is a risk of rupture of 1.2 % per year, and this risk increases in line with the diameter of the aneurysm. If rupture occurs, subarachnoid hemorrhage and its associated acute complications are responsible for high mortality (between 30 and 67 %) and morbidity (between 15 and 30 %).

Coil embolization of intracranial aneurysms has made remarkable technological progress since the International Subarachnoid Aneurysm Trial (ISAT) data were released in 2005. However, wide-necked aneurysms remain a great challenge to be treated via the endovascular means, as they are associated with a significantly greater incidence of adverse events when compared with narrow-necked ones.

Acutely ruptured wide-necked intracranial aneurysms pose technical challenges to the treating physician; thus, multiple endovascular techniques have been described to treat these lesions, including balloon-assisted coil placement, double microcatheter technique, and microcatheter assisted coil placement. However, the use of these techniques can sometimes be limited, owing to the lack of permanent support for the coil mass inside the aneurysm sac, which may lead to coil prolapse or migration after the procedure, especially for wide-necked aneurysms (dome-to-neck ratio is less than 1) or tiny aneurysms (3 mm). Therefore, surgical clipping is preferred for acutely ruptured wide-necked intracranial aneurysms in most institutions. Surgery, however, may also be challenging in some of these lesions, since clips may slip, and surgical access may be limited because of the swelling of the brain in the acute setting of a subarachnoid hemorrhage.

Flow diverters are new implantable medical devices that make possible to embolize wide-necked aneurysms without the use of coils; the efficacy results published to date are encouraging in terms of complete occlusion in the medium-term, thereby confirming the innovative nature of the flow diversion technique that we aim to evaluate without the use of coils. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03852680
Study type	Interventional
Source	Assiut University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 1, 2019
Completion date	March 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02345395` - Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms	N/A
Active, not recruiting	`NCT05626504` - Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
Completed	`NCT01716117` - Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms	N/A
Completed	`NCT04439760` - Superior Cervical Ganglion Block, Transcranial Doppler	N/A
Completed	`NCT04553549` - Safety and Feasibility of the Infinity Catheter for Radial Access
Completed	`NCT01975233` - WEB French Observatory of the WEB Aneurysm Embolization System
Terminated	`NCT01557036` - Aneurysm Study of Pipeline in an Observational Registry	N/A
Completed	`NCT02435823` - Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms	N/A
Completed	`NCT03844334` - CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms
Completed	`NCT01444664` - Aneurysm Wall Histology Registry	Phase 4
Recruiting	`NCT03936647` - The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices	N/A
Completed	`NCT02687607` - CLARYS: CLinical Assessment of WEB® Device in Ruptured aneurYSms
Withdrawn	`NCT02037932` - Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry	Phase 4
Recruiting	`NCT05317169` - Aneurysm Genetic Risk in Patients With QIB Changes
Terminated	`NCT00537134` - Trial on Endovascular Aneurysm Management	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.